{"organizations": [], "uuid": "e391b53634e5e9fb5a3a21cfd5927fc47c3b71a7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-insys-therapeutics-initiates-phase/brief-insys-therapeutics-initiates-phase-3-clinical-trial-of-cannabidiol-oral-solution-for-treatment-of-infantile-spasms-idUSASB0C8M7", "country": "US", "domain_rank": 408, "title": "BRIEF-Insys Therapeutics Initiates Phase 3 Clinical Trial Of Cannabidiol Oral Solution For Treatment Of Infantile Spasms", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-02T15:46:00.000+02:00", "replies_count": 0, "uuid": "e391b53634e5e9fb5a3a21cfd5927fc47c3b71a7"}, "author": "", "url": "https://www.reuters.com/article/brief-insys-therapeutics-initiates-phase/brief-insys-therapeutics-initiates-phase-3-clinical-trial-of-cannabidiol-oral-solution-for-treatment-of-infantile-spasms-idUSASB0C8M7", "ord_in_thread": 0, "title": "BRIEF-Insys Therapeutics Initiates Phase 3 Clinical Trial Of Cannabidiol Oral Solution For Treatment Of Infantile Spasms", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-insys therapeutics initiates phase", "sentiment": "negative"}, {"name": "cannabidiol oral solution for treatment of infantile spasms reuters", "sentiment": "none"}, {"name": "insys therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 2, 2018 / 1:49 PM / Updated 10 minutes ago BRIEF-Insys Therapeutics Initiates Phase 3 Clinical Trial Of Cannabidiol Oral Solution For Treatment Of Infantile Spasms Reuters Staff 1 Min Read March 2 (Reuters) - Insys Therapeutics Inc: * INSYS THERAPEUTICS INITIATES PHASE 3 CLINICAL TRIAL OF CANNABIDIOL (CBD) ORAL SOLUTION FOR TREATMENT OF INFANTILE SPASMS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-02T15:46:00.000+02:00", "crawled": "2018-03-02T16:02:29.024+02:00", "highlightTitle": ""}